These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 26722521)
1. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer. Wu W; Qian L; Chen X; Ding B Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells. Qiao N; Wang L; Wang T; Li H Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277 [TBL] [Abstract][Full Text] [Related]
3. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients. Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612 [TBL] [Abstract][Full Text] [Related]
4. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857 [TBL] [Abstract][Full Text] [Related]
5. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma. McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239 [TBL] [Abstract][Full Text] [Related]
7. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016 [TBL] [Abstract][Full Text] [Related]
8. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells. Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171 [TBL] [Abstract][Full Text] [Related]
9. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients. D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma. Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293 [TBL] [Abstract][Full Text] [Related]
11. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915 [TBL] [Abstract][Full Text] [Related]
12. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis. Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer. Long P; Sun F; Ma Y; Huang Y Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890 [TBL] [Abstract][Full Text] [Related]
17. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [TBL] [Abstract][Full Text] [Related]
18. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice. Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617 [TBL] [Abstract][Full Text] [Related]
19. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129 [TBL] [Abstract][Full Text] [Related]
20. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer. Nazari A; Khorramdelazad H; Hassanshahi G Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]